4 employees
RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.
2003
$1M
from 2 investors over 2 rounds
REGENEMED, INC. raised $1M on January 1, 2007
Investors: -
REGENEMED, INC. raised undisclosed on June 5, 2005